Phase II study of fosaprepitant plus 5HT3 receptor antagonists plus dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: Hoosier Oncology Group QL12-153.
Costantine Albany
No relevant relationships to disclose
Nasser H. Hanna
No relevant relationships to disclose
Joel Picus
No relevant relationships to disclose
Ralph J. Hauke
No relevant relationships to disclose
Christopher A. Fausel
Employment or Leadership Position - Hoosier oncology grroup
Ziyue Liu
No relevant relationships to disclose
Mary J. Brames
No relevant relationships to disclose
Lawrence H. Einhorn
No relevant relationships to disclose